Enstilar
Sponsors
L.H. Kircik, M.D., Derm Research, PLLC, Psoriasis Treatment Center of Central New Jersey, Bispebjerg Hospital, Aarhus University Hospital
Conditions
Nail PsoriasisPlaque PsoriasisPsoriasisPsoriasis VulgarisSkin DiseasesSkin Diseases, PapulosquamousSkin and Connective Tissue Diseases
Phase 2
Phase 4
Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
CompletedNCT03441789
Start: 2017-09-18End: 2018-10-22Updated: 2019-03-14
The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients
CompletedNCT03848871
Start: 2017-12-12End: 2018-12-10Updated: 2020-08-26
Taltz in Combination With Enstilar for Psoriasis
RecruitingNCT04372277
Start: 2020-04-28End: 2021-03-30Target: 25Updated: 2020-05-04
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
Active, not recruitingNCT05185258
Start: 2022-02-16End: 2026-07-15Target: 12Updated: 2025-10-03
Combination of Sotyktu and Enstilar for Plaque Psoriasis
CompletedNCT06329258
Start: 2022-12-06End: 2023-11-13Updated: 2024-03-25